LUYE PHARMA GROUP DL-,02 financial statements, including revenue, expenses, profit, and loss
The total revenue of LUP for the last semiannual is 405.89 M EUR, and it's 5.66% higher compared to the previous semiannual. The net income of H2 23 is 47.95 M EUR.